Exploring strategies for optimal capping to maximize mRNA potency
Capping is a crucial modification of in vitro–transcribed mRNAs, enhancing their stability, facilitating translation initiation, and enabling self/non-self discrimination in therapeutic applications. At its most basic level, capping involves the addition of a 7-methylguanosine (m7G) to the 5′ end of the mRNA generating a Cap-0 structure, which is often recognized as non-self in higher eukaryotes. The first transcribed base can also be methylated at the 2′ ribose position to generate the more common Cap-1 structure found on endogenous mRNAs in higher eukaryotes.
This tech note details a comprehensive evaluation of mRNA capping strategies, focusing on CleanCap® technology and its impact on mRNA quality and protein expression both in vitro and in vivo.
We report the following in this tech note:
- Evaluate mRNA quality using enzymatic and CleanCap capping methods
- Present protein expression data for three CleanCap cap analogs
- Compare in vivo protein expression of CleanCap M6 and enzymatic capping
- Demonstrate the possibility of dose reduction with CleanCap M6 mRNA
Offered Free by: TriLink
See All Resources from: TriLink
